Filtered By:
Cancer: Skin Cancer
Management: Electronic Health Records (EHR)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 34 results found since Jan 2013.
Ranitidine Use and Incident Cancer in a Multinational Cohort
CONCLUSIONS AND RELEVANCE: In this cohort study, ranitidine use was not associated with an increased risk of cancer compared with the use of other H2RAs. Further research is needed on the long-term association of ranitidine with cancer development.PMID:37725377 | DOI:10.1001/jamanetworkopen.2023.33495
Source: Cancer Control - September 19, 2023 Category: Cancer & Oncology Authors: Seng Chan You Seung In Seo Thomas Falconer Chen Yanover Talita Duarte-Salles Sarah Seager Jose D Posada Nigam H Shah Phung-Anh Nguyen Yeesuk Kim Jason C Hsu Mui Van Zandt Min-Huei Hsu Hang Lak Lee Heejoo Ko Woon Geon Shin Nicole Pratt Rae Woong Park Chris Source Type: research
Malignancy risk in patients with atopic dermatitis: a population-based cohort study
CONCLUSIONS: Epidemiological evidence does not support a strong overall malignancy risk in AD but lymphoma risk may be increased with severe AD.PMID:37418646 | DOI:10.1093/bjd/ljad072
Source: The British Journal of Dermatology - July 7, 2023 Category: Dermatology Authors: Joy Wan Daniel B Shin Maha N Syed Katrina Abuabara Adina R Lemeshow Zelma C Chiesa Fuxench Joel M Gelfand Source Type: research
Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control
CONCLUSIONS: We demonstrate that 22 (66%) patients experienced SDC, regardless of cancer type or development of irAE. After including patients who were re-challenged with ICI due to PD, 25 (71%) remain in DC. Future prospective malignancy-specific trials are warranted to evaluate optimal treatment duration.PMID:37115270 | DOI:10.1007/s00432-023-04812-0
Source: Clinical Lung Cancer - April 28, 2023 Category: Cancer & Oncology Authors: Harsh Sharma Krishna R Moturi Vernon S Pankratz Emrullah Yilmaz Olumide B Gbolahan Atul Kumar Neda Hashemi-Sadraei Source Type: research
Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
In conclusion, since smoking represents an independent modifiable poor prognostic factor in patients with cutaneous melanoma, smoking habits should be proactively asked about by healthcare professionals, in order to support smoking cessation.PMID:36748330 | DOI:10.2340/actadv.v103.3209
Source: Acta Derm Venereol A... - February 7, 2023 Category: Dermatology Authors: Kalle Mattila Helmi Vihinen Antti Karlsson Heikki Minn Pia Vihinen Eetu Heerv รค Source Type: research
